TABLE 2.

Distribution of combined GM 1,17 5,13 and KM 1,3 phenotypes in relation to persistence and clearance of HCV infection

PhenotypesNo. (%) of subjectsa with indicated HCV infection outcomeOR95% confidence intervalP
PersistentCleared
GM 1,17 5,13 (+)/KM 1,3 (+)9 (4.6)15 (15.6)3.571.44-8.870.006
GM 1,17 5,13 (+)/KM 1,3 (−)35 (18.0)14 (14.6)0.970.46-2.040.93
GM 1,17 5,13 (−)/KM 1,3 (+)53 (27.3)25 (26.0)1.120.62-2.050.70
GM 1,17 5,13 (−)/KM 1,3 (−)97 (50.0)42 (43.8)1.00
  • a Persistence, n = 194; clearance, n = 96; missing GM and/or KM typing, n = 8.